VolitionRX Limited VNRX Q1 2025 Annual earnings
Reported May 15, 2025 · After market close
Revenue$246.4KMiss by $837.6K
EPS-$0.06In line
Revenue estimate$1.1M
EPS estimate-$0.06
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$442.0K
EPS estimate-$0.70
Versus estimates
Revenue
Diluted EPS
Ask the moment VolitionRX Limited reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did VolitionRX Limited report Q1 2025 earnings?
- VolitionRX Limited (VNRX) reported Q1 2025 earnings on May 15, 2025 after market close.
- What were VolitionRX Limited's Q1 2025 revenue and EPS?
- VolitionRX Limited reported revenue of $246.4K and eps of $-0.06 for Q1 2025.
- Did VolitionRX Limited beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $1.1M by $837.6K. EPS beat the consensus estimate of $-0.06 by $0.00.
- How did VolitionRX Limited's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 43.6% from $171.5K a year earlier and eps grew 40.0% from $-0.10.
- Where can I find VolitionRX Limited's Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001477932-25-002231) directly on SEC EDGAR. The filing index links above go to sec.gov.